- Home
- Publications
- Publication Search
- Publication Details
Title
Docetaxel
Authors
Keywords
-
Journal
DRUGS
Volume 72, Issue 11, Pages 1559-1577
Publisher
Springer Nature
Online
2012-07-24
DOI
10.2165/11209660-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors
- (2012) Orazio Caffo et al. UROLOGY
- Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience
- (2012) Kazuhiko Nakano et al. BMC Urology
- Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer
- (2011) G. Sonpavde et al. ANNALS OF ONCOLOGY
- Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial‡
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial
- (2011) Orazio Caffo et al. BJU INTERNATIONAL
- The use of estramustine phosphate in the modern management of advanced prostate cancer
- (2011) Vincent Ravery et al. BJU INTERNATIONAL
- Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
- (2011) R Petrioli et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxel
- (2011) Frank Desarnaud et al. CANCER BIOLOGY & THERAPY
- Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer
- (2011) Gregory R. Pond et al. EUROPEAN UROLOGY
- Docetaxel as a vital option for corticosteroid-refractory prostate cancer
- (2011) Haruki Kume et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
- (2011) Wei-Xiang Qi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer
- (2011) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo
- (2011) J.Y. Henry et al. PROSTATE
- Feasibility of Tri-Weekly Docetaxel-Based Chemotherapy for Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer
- (2011) Natsuki Takaha et al. UROLOGIA INTERNATIONALIS
- Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer
- (2011) Ioannis Mountzios et al. UROLOGY
- Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines
- (2010) Robin Epplen et al. ACTA ONCOLOGICA
- Docetaxel-based combination therapy for castration-resistant prostate cancer
- (2010) M. D. Galsky et al. ANNALS OF ONCOLOGY
- A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer
- (2010) Joel Picus et al. CANCER
- Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer
- (2010) Jorge A. Garcia et al. CANCER
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
- (2010) M.-L. Zhu et al. CANCER RESEARCH
- Castration-Resistant Prostate Cancer
- (2010) Giuseppe Di Lorenzo et al. DRUGS
- Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: A new paradigm for understanding the therapeutic effect of combined treatment
- (2010) Cécile Ortholan et al. EUROPEAN JOURNAL OF CANCER
- Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients
- (2010) Yoshihiro Nakagami et al. INTERNATIONAL JOURNAL OF UROLOGY
- Docetaxel-Prednisolone Combination Therapy for Japanese Patients with Hormone-refractory Prostate Cancer: a Single Institution Experience
- (2010) N. Miura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer
- (2010) Ryan M. Franke et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Kim N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Yang-Min Ning et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
- (2009) T Koreckij et al. BRITISH JOURNAL OF CANCER
- Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer
- (2009) Trine Zeeberg Buch-Hansen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
- (2009) Andrew J. Armstrong et al. EUROPEAN JOURNAL OF CANCER
- Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients
- (2009) Norihito Soga et al. International Journal of Clinical Oncology
- PSA surge/flare-up in patients with castration-refractory prostate cancer during the initial phase of chemotherapy
- (2009) T. Nelius et al. PROSTATE
- Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial
- (2008) Orazio Caffo et al. BJU INTERNATIONAL
- A Phase I-II Study of Docetaxel and Atrasentan in Men with Castration-Resistant Metastatic Prostate Cancer
- (2008) A. J. Armstrong et al. CLINICAL CANCER RESEARCH
- Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study
- (2008) D. R. Berthold et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- A Phase II Study of Estramustine, Docetaxel, and Exisulind in Patients with Hormone- Refractory Prostate Cancer: Results of Cancer and Leukemia Group B Trial 90004
- (2008) Nancy A. Dawson et al. Clinical Genitourinary Cancer
- Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer
- (2008) Antoine Italiano et al. EUROPEAN UROLOGY
- Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan
- (2008) S. Naito et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer
- (2008) Jean-Pascal Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now